CorMedix Inc.
CRMD
$6.10
-$0.20-3.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 41,186.87% | 2,108.49% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 41,186.87% | 2,108.49% | -- | -- |
| Cost of Revenue | -- | 503,625.00% | 69,810.53% | 37,104.55% | -- |
| Gross Profit | -- | 34,873.72% | -1,609.25% | -1,574.77% | -- |
| SG&A Expenses | 63.94% | 102.53% | 106.17% | 89.12% | 78.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.46% | 51.59% | 54.27% | 57.63% | 59.53% |
| Operating Income | 54.34% | -22.27% | -52.31% | -57.89% | -59.87% |
| Income Before Tax | 58.30% | -19.47% | -47.71% | -52.67% | -53.00% |
| Income Tax Expenses | -- | -- | -- | -138.18% | -- |
| Earnings from Continuing Operations | 61.31% | -15.97% | -43.93% | -51.16% | -56.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.31% | -15.97% | -43.93% | -51.16% | -56.02% |
| EBIT | 54.34% | -22.27% | -52.31% | -57.89% | -59.87% |
| EBITDA | 54.90% | -22.02% | -52.27% | -58.05% | -60.08% |
| EPS Basic | 64.53% | 6.43% | -8.92% | -17.14% | -24.39% |
| Normalized Basic EPS | 61.88% | 3.60% | -11.77% | -18.02% | -21.97% |
| EPS Diluted | 64.53% | 6.43% | -8.92% | -17.14% | -24.39% |
| Normalized Diluted EPS | 61.88% | 3.60% | -11.77% | -18.02% | -21.97% |
| Average Basic Shares Outstanding | 15.76% | 23.14% | 32.80% | 29.91% | 26.30% |
| Average Diluted Shares Outstanding | 15.76% | 23.14% | 32.80% | 29.91% | 26.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
